Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer
NCT00870337
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
everolimus
Sponsor
ARCAGY/ GINECO GROUP